CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Mirna Therapeutics, Inc.  (MIRN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Mirna Therapeutics's Quick Ratio

MIRN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

MIRN Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change -96.79 % -70.06 % -90.21 % -76.87 % -
Y / Y Cash & cash equivalent Change -34.23 % -28.61 % -32.56 % 85.58 % -
Quick Ratio MRQ 1015.34 155.06 167.58 57.47 49.63
Overall Ranking # 1 # 28 # 28 # 0 #
Seq. Current Liabilities Change -87.33 % 2.77 % -68.69 % -21.14 % 18 %
Seq. Cash & cash equivalent Change -17.05 % -4.91 % -8.69 % -8.68 % -9.97 %



Quick Ratio second quarter 2017 Comment
Current Liabilities decreased faster than Mirna Therapeutics's Cash & cash equivalent, this led to improvement in Mirna Therapeutics's Quick Ratio to 1015.34, Quick Ratio remained below Mirna Therapeutics, Inc. average.

Within Biotechnology & Drugs industry Mirna Therapeutics, Inc. achieved highest Quick Ratio than Mirna Therapeutics in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are MIRN Segments?
See Quick Ratio MIRN on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 1
Overall Market # 1


Quick Ratio Statistics
High Average Low
1015.34 192.7 7.16
(Jun 30 2017)   (Sep 30 2015)


You need to upgrade your Flash Player


Financial Statements
Mirna Therapeutics's Current Liabilities $ 0 Millions Visit MIRN's Balance sheet
Mirna Therapeutics's Cash & cash equivalent $ 48 Millions Visit MIRN's Balance sheet
Source of MIRN's Sales Visit MIRN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Biotechnology & Drugs Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Mirna Therapeutics, Inc.  1,015.34 $ 47.721  Millions$ 0.047  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
VNJA's Profile
Stock Price
VNJA's Financials
VNJA's Expectations
Business Description
Fundamentals
Charts & Quotes
VNJA's News
Suppliers
VNJA's Competitors
Customers & Markets
Economic Indicators
VNJA's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com